Filing Details
- Accession Number:
- 0000885590-13-000096
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-05 17:03:28
- Reporting Period:
- 2013-11-01
- Filing Date:
- 2013-11-05
- Accepted Time:
- 2013-11-05 17:03:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885590 | Valeant Pharmaceuticals International Inc. | VRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1343811 | Ann Norma Provencio | 2150 St. Elzear Blvd. West Laval A8 H7L 4A8 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par Value | Disposition | 2013-11-01 | 5,000 | $106.70 | 158,647 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This number represents the weighted average sale price for all sales of common stock sold by the reporting officer pursuant to a 10b5-1 trading plan. Actual sale executions were in the range of $105.58 and $108.40. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price.
- This number represents common shares purchased and other equity awards that were previously reported in Table 1.
Billionaire Hedge Funds
